The hypothesis of TGF-β involvement in the chondrogenic activation of hAdMSCs could also be supported by previous studies that demonstrated that total TGF-β in CS from 80 patients was very high (97.93 ± 113.41 ng/ml) (Wehling et al., 2007). Here, TGFB1 is linked to Cowden syndrome 1.